Cargando…

Effectiveness of Prenatal Tdap Immunization in the Prevention of Infant Pertussis in the United States

BACKGROUND: The Centers for Disease Control and Prevention recommends that all pregnant women in the United States receive tetanus-diphtheria-acellular pertussis (Tdap) immunization to prevent infant pertussis. While the vaccine may be administered at any time during pregnancy, the recommendations d...

Descripción completa

Detalles Bibliográficos
Autores principales:	Becker-Dreps, Sylvia, Butler, Anne M, McGrath, Leah J, Boggess, Kim A, Weber, David J, Li, Dongmei, Hudgens, Michael G, Layton, J Bradley
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2017
Materias:	Abstracts
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5631687/ http://dx.doi.org/10.1093/ofid/ofx162.163

Ejemplares similares

Cost-Effectiveness Analysis of Tdap in the Prevention of Pertussis in the Elderly
por: McGarry, Lisa J., et al.
Publicado: (2013)

Durability and Kinetics of Maternal Pertussis Antibodies in Infants of Mothers Immunized with Tdap During Pregnancy
por: Healy, C Mary, et al.
Publicado: (2017)

2902. Pertussis Antibody Levels in Preterm Infants After Maternal Tdap Immunization During Pregnancy
por: Healy, C Mary, et al.
Publicado: (2019)

Trends in Antibiotic Treatment of Acute Otitis Media and Treatment Failure in Children, 2000–2011
por: McGrath, Leah J., et al.
Publicado: (2013)

Pharmacists’ Attitudes and Practices Regarding Tetanus, Diphtheria and Pertussis (Tdap) Vaccination in Pregnancy and Surrounding Newborns
por: Echtenkamp, Christine A, et al.
Publicado: (2018)

Perceptions of Tetanus-diphteria-acellular pertussis (Tdap) Vaccination among Korean Women of Childbearing Age
por: Kim, In Seon, et al.
Publicado: (2013)

Effect of maternal Tdap on infant antibody response to a primary vaccination series with whole cell pertussis vaccine in São Paulo, Brazil
por: Vaz-de-Lima, Lourdes R.A., et al.
Publicado: (2021)

Cost-Effectiveness of Tdap Vaccination of Adults Aged ≥65 Years in the Prevention of Pertussis in the US: A Dynamic Model of Disease Transmission
por: McGarry, Lisa J., et al.
Publicado: (2014)

Case-Control Study to Estimate the Association Between Tdap Vaccination During Pregnancy and Reduced Risk of Pertussis in Newborn Infants in Peru, 2019–2021
por: Juscamayta-López, Eduardo, et al.
Publicado: (2023)

Immunogenicity of a new enhanced tetanus-reduced dose diphtheria-acellular pertussis (Tdap) vaccine against Bordetella pertussis in a murine model
por: Kang, Kyu Ri, et al.
Publicado: (2021)

Factors Affecting the Implementation Process of Pertussis [Tdap] Immunization in Pregnant Women in an Italian Region: A Qualitative Study
por: Mazzilli, Sara, et al.
Publicado: (2020)

Tdap vaccination in pregnancy
por: Dalcin, Daniel, et al.
Publicado: (2021)

1483. Maternal Tdap Vaccination During Pregnancy and Immune Response: A Comparison Between Infants Born to Mothers Primed with Acellular or Whole Cell Pertussis Vaccines
por: Havers, Fiona, et al.
Publicado: (2020)

Changes in Pneumonia Incidence and Infant Mortality 5 Years Following Introduction of the 13-valent Pneumococcal Conjugate Vaccine in a “3+0” Schedule in Nicaragua
por: Becker-Dreps, Sylvia, et al.
Publicado: (2017)

Safety and immunogenicity of a combined Tetanus, Diphtheria, recombinant acellular Pertussis vaccine (TdaP) in healthy Thai adults
por: Sirivichayakul, Chukiat, et al.
Publicado: (2016)

A study of acceptance and hesitation factors towards tetanus, diphtheria, and acellular pertussis (Tdap) and influenza vaccines during pregnancy
por: Quiles, Raquel, et al.
Publicado: (2023)

Changes in the incidence of pneumonia, bacterial meningitis, and infant mortality 5 years following introduction of the 13-valent pneumococcal conjugate vaccine in a "3+0" schedule
por: Becker-Dreps, Sylvia, et al.
Publicado: (2017)

Infant outcomes after exposure to Tdap vaccine in pregnancy: an observational study
por: Walls, Tony, et al.
Publicado: (2016)

Tdap vaccination during pregnancy and risk of chorioamnionitis and related infant outcomes
por: Greenberg, Victoria, et al.
Publicado: (2023)

A phase I, randomized, controlled, dose-ranging study of investigational acellular pertussis (aP) and reduced tetanus-diphtheria-acellular pertussis (TdaP) booster vaccines in adults
por: Leroux-Roels, Geert, et al.
Publicado: (2017)

Estimating the role of casual contact from the community in transmission of Bordetella pertussis to young infants
por: Wendelboe, Aaron M, et al.
Publicado: (2007)

On inverse probability-weighted estimators in the presence of interference
por: Liu, L., et al.
Publicado: (2016)

Blue Nevus Developing at a Combined Tetanus, Diphtheria, and Pertussis (Tdap) Vaccination Site: Case Report and Summary of Vaccine-Associated Cutaneous Lesions
por: Kim, Yoo Jung, et al.
Publicado: (2019)

“When you are injected, the baby is protected:” Assessing the acceptability of a maternal Tdap vaccine based on mothers’ knowledge, attitudes, and beliefs of pertussis and vaccinations in Lusaka, Zambia
por: Larson Williams, Anna, et al.
Publicado: (2018)

Factors Influencing Maternal Antepartum Tdap Vaccination
por: Bernstein, Henry H., et al.
Publicado: (2022)

Tdap Vaccination Coverage During Pregnancy — Selected Sites, United States, 2006–2015
por: Kerr, Stephen, et al.
Publicado: (2017)

Influenza and Tdap Vaccination Coverage Among Pregnant Women — United States, April 2018
por: Kahn, Katherine E., et al.
Publicado: (2018)

Influenza and Tdap Vaccination Coverage Among Pregnant Women — United States, April 2020
por: Razzaghi, Hilda, et al.
Publicado: (2020)

Randomized Controlled Trial of the Safety and Immunogenicity of Revaccination With Tetanus-Diphtheria-Acellular Pertussis Vaccine (Tdap) in Adults 10 Years After a Previous Dose
por: Halperin, Scott A, et al.
Publicado: (2018)

Feeding Behaviors in Infants With Prenatal Opioid Exposure: An Integrative Review
por: McGlothen-Bell, Kelly, et al.
Publicado: (2020)

Antibody persistence 2 and 3 years after booster vaccination of adolescents with recombinant acellular pertussis monovalent aP(gen) or combined TdaP(gen) vaccines
por: Pitisuttithum, Punnee, et al.
Publicado: (2021)

Patterns of Rotavirus Vaccine Uptake and Use in Privately-Insured US Infants, 2006–2010
por: Panozzo, Catherine A., et al.
Publicado: (2013)

Combined Reduced-Antigen Content Tetanus, Diphtheria, and Acellular Pertussis (Tdap) Vaccine-Related Erythema Nodosum: Case Report and Review of Vaccine-Associated Erythema Nodosum
por: Cohen, Philip R.
Publicado: (2013)

Preliminary study on the immunogenicity of a newly developed GCC Tdap vaccine and its protection efficacy against Bordetella pertussis in a murine intranasal challenge model
por: Han, Seung Beom, et al.
Publicado: (2015)

Updated Recommendations for Use of Tetanus Toxoid, Reduced Diphtheria Toxoid, and Acellular Pertussis Vaccine (Tdap) in Pregnant Women — Advisory Committee on Immunization Practices (ACIP), 2012
por: Sawyer, Mark, et al.
Publicado: (2013)

Safety and use of tetanus-diphtheria-acellular pertussis-5 (Tdap5) vaccine during pregnancy: findings from 11 years of reporting to a pregnancy registry
por: Switzer, Charlotte, et al.
Publicado: (2021)

Rotavirus Vaccine Schedules and Vaccine Response Among Infants in Low- and Middle-Income Countries: A Systematic Review
por: Gruber, Joann F., et al.
Publicado: (2017)

A Retrospective Cohort Study of Safety Outcomes in New Zealand Infants Exposed to Tdap Vaccine in Utero
por: Petousis-Harris, Helen, et al.
Publicado: (2019)

Recommendation for the use of newly introduced Tdap vaccine in Korea
por: Choi, Kyong Min, et al.
Publicado: (2011)

Safety of Tdap vaccine in pregnant women: an observational study
por: Petousis-Harris, Helen, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_uc218ucphs0tge832t0fudlbat